Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $123,572,107    

Indirect Value

   $38,933,066      
Total Shares   87,362,343      
Total Value   $162,505,173      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $32,828,639 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $3,772,082 Achieve Life Sciences Inc $4,202,004 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $76,429 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $19,586,754 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $32,828,639 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $3,772,082 Achieve Life Sciences Inc $4,202,004 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $76,429 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $19,586,754 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 21 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-11-22 4 B $1.20 $42,210 D/D 35,200 16,040,000 3.92 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2019-03-27 4 B $0.35 $42,226 D/D 120,647 17,383,500 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-05-16 4 B $5.15 $42,240 D/D 8,202 18,332,487 3.92 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2019-05-20 4 B $4.24 $42,400 D/D 10,000 1,020,000 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-11-15 4 B $3.78 $42,621 D/D 11,218 17,800,900 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-09-25 4 B $4.60 $42,749 D/D 9,296 17,489,296 3.92 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-04-26 4 B $0.54 $43,016 D/D 80,000 16,412,500 2.37 -
TENX Tenax Therapeutics Inc Director   –       •       •   2020-09-01 4 B $1.46 $43,800 D/D 30,000 1,931,995 3.92 %
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-10 4 B $0.79 $43,954 I/I 55,638 3,273,878 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-16 4 B $0.58 $44,544 D/D 76,800 15,642,300 2.37 -
DFRG Del Friscos Restaurant Gr... 10% Owner   –       –       •   2019-01-29 4 B $7.67 $44,550 D/D 5,779 4,570,000 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-12 4 B $3.20 $44,704 I/I 13,970 313,970 2.25 -
AYTU AYTU BIOSCIENCE, INC Director   –       •       •   2019-12-19 4 B $0.85 $44,870 D/D 52,788 7,924,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-02-18 4 B $0.82 $45,238 I/I 55,000 46,617,000 2.25 %
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2019-05-23 4 B $2.28 $45,600 D/D 20,000 1,056,000 2.37 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2018-08-17 4 S $0.95 $45,682 D/D (48,000) 2,172,000 0 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2019-05-17 4 B $0.23 $46,000 D/D 200,000 20,200,000 2.37 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2018-04-25 4 B $0.54 $46,250 D/D 85,522 16,332,500 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-10 4 B $3.36 $46,397 D/D 13,815 18,040,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-04-19 4 B $3.57 $47,195 D/D 13,211 16,213,211 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-06-03 4 B $4.73 $47,300 D/D 10,000 18,424,285 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-09 4 B $0.66 $47,598 I/I 72,118 3,246,059 1.5 -
CYTH Cyclo Therapeutics, Inc 10% Owner   –       –       •   2020-09-10 4 S $0.17 $48,025 D/D (282,500) 16,523,576 0 %
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-06-11 4 B $3.80 $48,689 D/D 12,813 1,026,000 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-17 4 B $3.26 $48,701 D/D 14,938 18,082,970 3.92 -
  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21  22   23   24   25   26   27   28   29   30   31   32      
  Page 21 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us